Dr Anastasia Constantinidou graduated with a first class from the Medical School of the National and Kapodistrian University in Athens Greece (MD). She gained Membership of the Royal College of Physicians (MRCP) in the UK and she subsequently completed her specialist clinical training in Internal Medicine and her specialist clinical training in Medical Oncology (CCT) at the Royal Marsden Hospital in London (2011). She gained an MSc in Oncology (Merit) from the University of London and she was awarded a Wellcome Trust Fellowship for laboratory research in Molecular Pathology for her four-year PhD studies at the Institute of Cancer Research, University of London.

Her basic science research has focused on the identification of genes involved in the process of cell differentiation as novel targets in cancer therapeutics with emphasis on epigenetics. Her clinical and translational research expertise is based on first-hand experience in participating in UK, European and international clinical and translational trials as a principal or co-investigator including first in human (phase I) clinical trials. She has been awarded a number of fellowships throughout her career including the Hellenic Society of Medical Oncology Clinical Training Fellowship and the ECCO-AACR-EORTC-ESMO Fellowship in Methods in Clinical Cancer Research Workshop as well as grants from the Wellcome Trust UK, the Sarcoma UK, the Research and Innovation Foundation (RIF Cyprus), the Horizon 2020 and the Horizon Europe Research and Innovation Programmes. She is currently involved in several research projects including CARDIOCARE (funded by HORIZON 2020, local PI), ECHOs (funded by HORIZON Europe, local PI), ECAN (funded by EU4Health, local clinical PI), E CAN PLUS (EU4Health, local clinical PI), BIOBREAST (funded by RIF, PI).

 

Dr Constantinidou was the recipient of the 2020 Young Investigator Award in Life Sciences by the RIF.

Through competitive selection, she has presented her work in many international conferences including the American Society of Clinical Oncology (ASCO), the European Society for Medical Oncology (ESMO) and the Connective Tissue Oncology Society (CTOS) annual conferences for over a decade. She has authored publications in high impact factor peer-reviewed journals including the Lancet Oncology, the Nature Reviews Clinical Oncology, the Annals of Oncology, the European Journal of Cancer, the British Journal of Cancer and Pharmacology & Therapeutics. She serves as a reviewer and an editorial board member in oncology and medical journals. She has been an invited speaker and chair on topics related to her research and clinical work nationally (UK, Cyprus) and internationally. She has served as an invited organizing committee member in the annual ESMO Asia and annual ESMO conferences. She has been a Faculty member of the European School of Oncology programme for oncology trainees and junior oncologists, since 2017 (Principles in Oncology Meeting, Southern Europe and Arab Countries Meeting). 

Dr Constantinidou is the coordinator of the first postgraduate programme of the Medical School of the UCY, entitled Precision Medicine in Clinical Practice, which enrolled its first students in September 2021. She was a member of the National Bioethics Committee (2018-2024) and the National Committee for Laboratory Animal Welfare 2018 - 2021). She is the coordinator of the National Affiliated Centre of the European Reference Network EURACAN Rare Adult Solid Cancers and she has been a member of the Steering Committee of EURACAN since 2022. She is the Representative of Cyprus in the ESMO National Societies Committee. She has been the president of the Cyprus Oncology Society Board since 2023 and though this role she led the organisation of the 1st Cyprus Oncology Congress in February 2025.